EDUCATION 

Please check the time for your location here.

Free registration

Register 

Join ICHS for an interactive, case-based webinar where real-world scenarios set the stage for a dynamic discussion on the latest evidence and the outlook of Managing Bacterial Resistance in Neutropenia.

Dr. Malgorzata Mikulska will facilitate a moderated discussion with the presenters to provide attendees with both the scientific rationale and the clinical context for managing bacterial resistance in neutropenia. 

During the webinar we will review:

• State-of-the-art management of febrile neutropenia in the era of resistant bacteria
• Worldwide vision & Global perspectives: Regional differences in applying guidelines
  

• Local epidemiology of bacterial resistance in neutropenia, implications for empirical therapy, and targeted treatment of MDR pathogens (CRE, P. aeruginosa, and S. maltophilia), considering access to newer antibiotics.

  Followed by Global Panel Discussion and Q&A

Whether you are looking to sharpen your clinical reasoning or stay ahead of emerging trends, this session offers evidence driven insight and actionable takeaways.

Dina Averbuch, MD:  Faculty of Medicine, Hebrew University of Jerusalem, Hadassah Medical Center, Jerusalem, Israel. Dr. Dina Averbuch is a Head of Paediatric Infectious Diseases Unit in Hadassah University Hospital in Jerusalem, Israel. Her research primarily concerns infections in immune-compromised hosts — in patients with cancer, following hematopoietic stem cell transplantation (HSCT), and in children with primary immune deficiencies. She participates in the European Conference of Infections in Leukaemia group (ECIL); and she is a Secretary of Infectious Diseases Working Party (IDWP) of the EBMT. She authored and co-authored 100 manuscripts including original articles, international guidelines and reviews; and chapters in five books; with a total of 3838 citations; H index 27. She led several international studies within the EBMT, including study of antimicrobial resistance among Gram-negative rods, nocardiosis and listeriosis in HCT patients

Dr. Murat Akova is a Professor of Medicine and Infectious Diseases at Hacettepe University School of Medicine in Ankara, Turkey. His clinical and research interests include antimicrobial resistance and infections in immunocompromised patients, particularly Gram-negative bacterial infections. He previously served as President of the Immunocompromised Host Society.

Dr. Marjorie Vieira Batista is an Infectious Diseases physician at A.C. Camargo Cancer Center in São Paulo, Brazil, where she specializes in infections in immunocompromised and transplant patients. Her academic and research work focuses on infectious complications in transplant and leukemia populations, supported by advanced training in Brazil and at MD Anderson Cancer Center.

Dr. Ronen Ben-Ami is a Professor of Medicine in the Department of Infectious Diseases at Tel Aviv Sourasky Medical Center and Tel Aviv University, where he also directs the National Reference Mycology Laboratory. His work focuses on the epidemiology, resistance mechanisms, and virulence of fungal pathogens, particularly in immunocompromised patients.

Dr. Neha Rastogi Panda, is a Senior Consultant in Infectious Diseases at Fortis Memorial Research Institute in Gurugram, India. Her expertise includes transplant infectious diseases, antimicrobial stewardship, infection prevention, and emerging infections in oncology and critical care. She serves as Country Ambassador for the International Immunocompromised Host Society and contributes to international guideline development. Dr. Rastogi Panda has authored more than 25 peer-reviewed publications and leads infection management initiatives in advanced immunotherapy programs.

Dr. Malgorzata Mikulska is an Associate Professor of Infectious Diseases at the University of Genova and a consultant at IRCCS Ospedale Policlinico San Martino in Italy. Dr. Mikulska is a highly accomplished researcher with over 300 publications and an H-index of 54. Her work focuses on infections in immunocompromised patients, particularly those with hematologic disorders and stem cell transplants, as well as invasive fungal infections. She is also an active contributor to numerous additional international scientific societies.

Dr. Maha Alamri is a Transplant Infectious Disease Consultant at the King Faisal Specialist Hospital and Research Center (KFHRC), in Riyadh, Saudi Arabia.

Dr. Patricia Costantini is an infectious diseases specialist whose clinical and research work focuses on infectious complications in patients with solid tumors and hematologic malignancies. She is a leader in infectious diseases in Argentina, contributing to national guidelines and advancing education and research in infections among immunocompromised patients.

Dr. Claudia Salgueira is a faculty member in the Department of Infectious Diseases and Infection Control at Sanatorio Anchorena and Sanatorio Trinidad Mitre in Buenos Aires, Argentina. Her work focuses on infectious complications in patients with hematologic malignancies and hematopoietic stem cell transplant recipients, with leadership contributions to the Argentinian Society of Infectious Diseases.

Please contact admin@ichs.org if you need any assistance.